Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Neumedicines joins the Alliance for Biosecurity

Jan. 7, 2014

Takeda submits NDA for fomepizole in Japan

Dec. 30, 2013

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Characterization of novel cocaine metabolizing enzymes for treatment of addiction

Dec. 10, 2013

VMY-2-109 treatment leads to reduction in nicotine self-administration in vivo

Nov. 27, 2013

SUVN-A60203 and its effects on alcohol consumption

Nov. 21, 2013

BARDA exercises option for continued development of AverTox against nerve agents

Nov. 18, 2013

Otsuka and Lundbeck partner for nalmefene in Japan

Nov. 5, 2013

AEOL-10150 improves survival in mice exposed to lethal radiation

Oct. 31, 2013

FDA accepts filing for Bunavail NDA

Oct. 10, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...